📰 Vision Biotech News
Vision Biotech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vision Biotech. Real-time updates on events, politics, business and more.
May 23, 2023
The prevalence of dry eye disease has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of dry eye disease and the growing
May 23, 2023
/PRNewswire/ -- DelveInsights Dry Eye Disease Pipeline Insight – 2023 report provides comprehensive global coverage of pipeline dry eye disease therapies in...
January 8, 2023
VivaVision and Everads Collaborate to Develop Durable and Effective Therapies for Retinal Diseases - read this article along with other careers information, tips and advice on BioSpace
January 6, 2023
/PRNewswire/ -- VivaVision, a pharmaceutical company developing innovative therapies for ocular diseases, and Everads Therapy, a biotech company developing...
October 19, 2022
/PRNewswire/ -- The "Facial Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
March 23, 2022
VivaVision Biotech has reported positive topline data from a Phase II clinical trial of VVN001 in dry eye disease patients.
February 21, 2022
/PRNewswire/ -- The "Dermal Facial Fillers Market" report has been added to ResearchAndMarkets.coms offering. The global dermal facial fillers market reached...
December 31, 2020
Share this article Share this article ResearchAndMarkets.coms offering. The global facial injectables market grew at a CAGR of around 14% during 2014-2019. facial injectables are administered on specific areas of the face to enhance the physical appearance of the skin. These injectables are generally made using collagen, hyaluronic acid and calcium hydroxylapatite that help restore the elasticity of the skin. They are used to reduce wrinkles, augment lips, enhance shallow contours and raise de...